RenovoRx, Inc. (RNXT): R&D Expense
$6.27M
Year ended 2025-12-31
$5.63M
Trailing 12 months to 2026-06-30
+13.4%
3-year compound annual growth
+21.3%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $6.27M | +4.0% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $6.03M | +6.3% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $5.67M | +31.8% | 2025-04-01, From 2023-01-01 |
| 2022-12-31 | $4.30M | +41.5% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $3.04M | +27.4% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $2.39M | n/a | 2022-03-30, From 2020-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| RenovoRx, Inc. (RNXT) | 2025-12-31 | $6.27M | +4.0% |
| PetVivo Holdings, Inc. (PETV) | 2026-03-31 | $1.42M | -10.6% |
| SeaStar Medical Holding Corp (ICU) | 2025-12-31 | $7.52M | -17.4% |
| Sintx Technologies, Inc. (SINT) | 2025-12-31 | $4.59M | -11.8% |
| Catheter Precision, Inc. (VTAK) | 2025-12-31 | $862.0K | +216.9% |
| EBR Systems, Inc. (NONE.) | 2025-12-31 | $23.94M | -11.5% |
| Harvard Apparatus Regenerative Technology, Inc. (HRGN) | 2025-12-31 | $2.65M | +14.8% |
| Vycor Medical Inc (VYCO) | 2025-12-31 | $10.0K | -35.0% |
| Co-Diagnostics, Inc. (CODX) | 2025-12-31 | $19.14M | -8.8% |
Compare RNXT, PETV, ICU, SINT side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗